Incannex Healthcare Inc
incannex.comWhat Do They Do?
Develops oral combination medicines and treatments pairing psychedelic medicines with psychological therapy for people with sleep apnea, anxiety and inflammatory conditions.
10-K for FY2026, filed Sep 25, 2026We are a clinical-stage biopharmaceutical company developing oral fixed-dose combination therapies and psychedelic-assisted treatments for…View ↗
IHL-42X, our lead drug candidate for the treatment of obstructive sleep apnea (“OSA”), is an oral fixed-dose combination of dronabinol and…View ↗
PSX-001, our other lead drug candidate in clinical development following completion of a Phase 2 trial, is an oral synthetic psilocybin…View ↗
IHL-675A is our drug candidate for the treatment of inflammatory conditions, with an initial focus on rheumatoid arthritis. IHL-675A is an…View ↗
Who Are Their Customers?
Clinic patients were the customers for rehabilitation services.
10-K for FY2026, filed Sep 25, 2026During the fiscal year ended June 30, 2025, we generated revenue from clinic patients for rehabilitation services. This figure reflects the…View ↗
How Are They Changing?
A narrower development focus
The earlier report described cannabinoid and psychedelic programs spanning many conditions; the latest centers development on sleep apnea and anxiety treatments, while inflammatory programs remain under evaluation.
20-F for FY2023, filed Oct 31, 2023 10-K for FY2026, filed Sep 25, 2026We develop targeted and scientifically validated fixed-dose combinations of cannabinoids with generic partners, unique formulations of…View ↗
Who Do They Compete With?
Competes with Apnimed, Mineralys Therapeutics, Helus Pharma, Otsuka Pharmaceutical Development & Commercialization, Sunovion Pharmaceuticals, Definium Therapeutics, AtaiBeckley, Compass Pathways, GH Research, Pfizer, AbbVie, Amgen, Novartis, Boehringer Ingelheim International, Eli Lilly and, F. Hoffmann-La Roche, Bristol Myers Squibb, AstraZeneca, and Merck &
10-K for FY2026, filed Sep 25, 2026Our competitors also may compete with us in recruiting and retaining qualified scientific and management personnel, in establishing…View ↗
Loading...
